Hirudin and Excess Bleeding Implications For Future Use

This publication has 27 references indexed in Scilit:

• Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators.
  Circulation, 1994
• Direct thrombin inhibitors in cardiovascular medicine.
  Circulation, 1994
• Frequency of achieving optimal reperfusion with thrombolysis in acute myocardial infarction (analysis of four German multicenter studies)
  The American Journal of Cardiology, 1994
• The development of hirudin as an antithrombotic drug
  Thrombosis Research, 1994
• The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction
  New England Journal of Medicine, 1993
• Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: Retrospective analysis of four german multicenter studies
  Journal of the American College of Cardiology, 1993
• Hirudins: Antithrombin Anticoagulants
  Annals of Pharmacotherapy, 1992
• Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation
  Journal of the American College of Cardiology, 1990
• EVALUATION OF THE INHIBITION BY HEPARIN AND HIRUDIN OF COAGULATION ACTIVATION DURING R-TPA-INDUCED THROMBOLYSIS
  1989
• Cloning and expression of a cDNA coding for the anticoagulant hirudin from the bloodsucking leech, Hirudo medicinalis.
  Proceedings of the National Academy of Sciences, 1986